RPRX icon

Royalty Pharma
RPRX

Overview Fund Activity

231 hedge funds and large institutions have $9.59B invested in Royalty Pharma in 2021 Q3 according to their latest regulatory filings, with 36 funds opening new positions, 92 increasing their positions, 78 reducing their positions, and 38 closing their positions.

Holders
231
Holders Change
-4
Holders Change %
-1.7%
% of All Funds
4.06%
Holding in Top 10
11
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+22.22%
% of All Funds
0.19%
New
36
Increased
92
Reduced
78
Closed
38
Calls
$45.5M
Puts
$17.1M
Net Calls
+$28.4M
Net Calls Change
+$41.8M

Top Buyers

1
Berkshire Hathaway
1
Berkshire Hathaway
Nebraska
$475M
2
Morgan Stanley
2
Morgan Stanley
New York
$2.07B
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$1.09B
4
BlackRock
4
BlackRock
New York
$559M
5
Geode Capital Management
5
Geode Capital Management
Massachusetts
$151M

Top Sellers

1
Capital International Investors
1
Capital International Investors
California
$180M
2
Fidelity Investments
2
Fidelity Investments
Massachusetts
$691M
3
JPMorgan Chase & Co
3
JPMorgan Chase & Co
New York
$192M
4
VCG
4
Vantage Consulting Group
Virginia
$284M
5
Amundi
5
Amundi
France
$50.4M
Name Market Value Shares Shares
Change 		Shares
Change %
Morgan Stanley
1
Morgan Stanley
New York
$2.07B 57,305,311 +6,511,270 +13%
Vanguard Group
2
Vanguard Group
Pennsylvania
$1.09B 30,028,062 +5,685,862 +23%
Adage Capital Partners
3
Adage Capital Partners
Massachusetts
$893M 24,697,815 +1,976,000 +9%
Fidelity Investments
4
Fidelity Investments
Massachusetts
$691M 19,109,757 -4,986,172 -21%
BlackRock
5
BlackRock
New York
$559M 15,460,845 +5,173,204 +50%
Berkshire Hathaway
6
Berkshire Hathaway
Nebraska
$475M 13,145,902 +13,145,902 New
VCG
7
Vantage Consulting Group
Virginia
$284M 7,862,542 -1,439,903 -15%
HMC
8
Harvard Management Company
Massachusetts
$258M 7,142,856 – –
SGA
9
Siguler Guff Advisers
New York
$244M 6,761,970 – –
State Street
10
State Street
Massachusetts
$211M 5,834,745 +967,111 +20%
JPMorgan Chase & Co
11
JPMorgan Chase & Co
New York
$192M 5,316,482 -1,998,519 -27%
Capital International Investors
12
Capital International Investors
California
$180M 4,987,467 -11,955,241 -71%
Geode Capital Management
13
Geode Capital Management
Massachusetts
$151M 4,168,049 +2,183,363 +110%
Viking Global Investors
14
Viking Global Investors
Connecticut
$150M 4,140,508 +901,854 +28%
Wellington Management Group
15
Wellington Management Group
Massachusetts
$113M 3,128,405 -1,175,121 -27%
Norges Bank
16
Norges Bank
Norway
$103M 2,860,730 +65,778 +2%
MSKCC
17
Memorial Sloan Kettering Cancer Center
New York
$96.9M 2,680,644 – –
Janus Henderson Group
18
Janus Henderson Group
United Kingdom
$85.4M 2,362,294 -1,383,120 -37%
T. Rowe Price Associates
19
T. Rowe Price Associates
Maryland
$79.4M 2,196,736 -3,117 -0.1%
Bank of America
20
Bank of America
North Carolina
$68.3M 1,889,651 +297,095 +19%
Aberdeen Group
21
Aberdeen Group
United Kingdom
$65.1M 1,801,145 -82,866 -4%
Bank of New York Mellon
22
Bank of New York Mellon
New York
$61.5M 1,702,989 +709,683 +71%
Northern Trust
23
Northern Trust
Illinois
$60.3M 1,668,674 +450,183 +37%
SCM
24
Suvretta Capital Management
New York
$55.2M 1,527,900 +798,523 +109%
TCM
25
TimesSquare Capital Management
New York
$54.9M 1,520,000 +18,440 +1%
1
2 3 4 5